Increased body mass index, concurrent chemotherapy, epidermal growth factor receptor (EGFR) mutations, increased age, preexisting ILD, tumor infiltration, and concurrent obstruction of central airways are risk factors for early (less than 3 months) occurrence of pneumonitis [42,43]. This evidence concerns the gene EGFR and pneumonitis.